Skip to main content Skip to search Skip to main navigation
News: International

Operation PANGEA XIV: Worldwide week of action against criminal online trade in medicines

Once a year, operation PANGEA takes place, a globally organized action by Interpol against the online distribution of illegally imported medicines. Within this week of action, participating countries check (and close) suspicious websites and seize counterfeit medicines. In addition, this action aims to create public awareness of the issue.

This year, PANGEA took place for the 14th time: From May 18 to 25, a total of 92 countries participated. In the process, 120,000 websites were assessed and 113,000 websites were closed. 9 million illegal and counterfeit medicines were seized. Among them were mainly counterfeit medical masks and COVID-19 test kits. Swissmedic also adds that potency drugs also made up a large proportion of the seized medicines. Most of the medicines confiscated in Switzerland were manufactured in Asian countries. Of the seized shipments, 41% came from Poland and 16% came from Germany.

Counterfeit medicines pose a major health risk if taken incorrectly. They either contain no active ingredient or less than the drug is supposed to have. 


Source:

Interpol: Newsroom 

Swissmedic: Newsroom

Meet the GMP Compliance Adviser

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business. 

The demo access is non-binding and ends automatically.

Test it now for free

You may also be interested in the following articles:

Save Time and Money when Qualifying a Blister Packaging Line

Save Time and Money when Qualifying a Blister Packaging Line

Qualifying a blister packaging line is not only technically demanding, but also time-consuming and costly. Here you will find important tips on how to organise your qualification process in a cost-effective yet gmp-compliant manner.

Read more
Question of the Week | GMP-Verlag

What is the Role of the Logistics Service Provider?

Here's the answer:
Read more
News: EMA

EMA: Latest Report on the International GMP Inspection Programme for API Manufacturers

EMA has published a new report on the International Active Pharmaceutical Ingredient Inspection Programme, covering the period 2017–2024. During this time, the number of participating authorities increased from ten to 13. Information was shared on 936 inspected sites and 1,684 inspections.
Read more
News: EMA

EMA Updates Procedure for Coordinating GMP Inspections

EMA has updated its procedure for coordinating GMP inspections for centrally authorised medicinal products. Version 3 has applied since 10 September 2026 and replaces Version 2. The document forms part of the Compilation of Union Procedures on Inspections and Exchange of Information (CoUP), which comprises the EU procedures and templates for GMP and GDP inspections.
Read more
Swissmedic Updates Guidance on GMP Compliance of Foreign Manufacturers

Swissmedic Updates Guidance on GMP Compliance of Foreign Manufacturers

Swissmedic has revised its guidance document “GMP compliance by foreign manufacturers”. The new Version 7.0 has been valid since 7 September 2026. In particular, it introduces new provisions for demonstrating the GMP compliance of manufacturers inspected by the US FDA. 
Read more
Swissmedic Updates Requirements for Cooperation with Pre-Wholesalers

Swissmedic Updates Requirements for Cooperation with Pre-Wholesalers

Swissmedic has revised its Technical Interpretation “Market release and distribution in cooperation with a pre-wholesaler”. The document addresses market release and distribution where a Marketing Authorisation Holder works with a pre-wholesaler (logistics and distribution service provider).
Read more
Previous
Next